New York, March 2, 2026, 07:10 EST — Premarket
- CoreWeave appears set for a quieter open ahead of Monday’s U.S. cash session.
- Investors are zeroing in on the company’s aggressive outlays and the implications for margins in the next few quarters.
- Executives made the rounds at investor conferences this week.
CoreWeave (CRWV) shares dropped 3.6% premarket Monday, ticking down to $76.71 after closing Friday at $79.56. Trading volume before the open was about 229,000 shares, Investing.com data showed.
The AI cloud firm jolted investors late last week, unveiling a massive capital plan—$30 billion to $35 billion marked for 2026. Most of that outlay is earmarked for Nvidia chips, data center buildouts, and securing energy. “We decided to build faster,” CEO Michael Intrator told Reuters, conceding the move would mean “some short-term pressure on the margins.” The company’s adjusted operating income margin dropped sharply, sliding to 6% in the December quarter from 16% a year earlier. Reuters
CoreWeave landed on the Nasdaq in March 2025 and isn’t slowing down—its executive team is on the road for a string of tech investor conferences. Co-founder and chief development officer Brannin McBee will appear at Morgan Stanley’s TMT event on March 4. Six days later, Nick Robbins, who leads corporate development and investor relations, heads to Cantor’s Global Technology conference.
CoreWeave reported fourth-quarter revenue at $1.572 billion, but finished the period with a net loss of $452 million, its earnings release shows. CFO Nitin Agrawal pointed to a revenue backlog now totaling $66.8 billion—representing contracted orders yet to be booked. Net interest expense tallied $388 million. On the funding front, CoreWeave pulled in roughly $2.6 billion via convertible senior notes and boosted its revolving credit line to $2.5 billion.
The spending blueprint is still the sticking point. As Reuters reports, CoreWeave ended 2025 holding $3.13 billion in cash, but it’s now eyeing an aggressive capex leap in 2026—to the tune of $30 billion to $35 billion, more than double what it shelled out last year. That level of outlay lines up with the biggest AI players. For smaller neocloud names, though, the risk becomes obvious if market conditions tighten. “Markets get the need for speed,” said Russ Mould, investment director at AJ Bell, but he flagged questions on “the long-term economics” and how all this spending will be financed. Rival Nebius is dialing up capex as well, with smaller neocloud firms scrambling to match the surge in demand. Reuters
Views aren’t lining up among analysts. Mark Murphy at JPMorgan cut his target on the stock to $90 from $110, citing an investment cycle that’s “more pronounced than expected.” Gregg Moskowitz at Mizuho dropped his number too, going with $95 instead of $100. Stifel’s Ruben Roy described the company as being in a “catch-up” phase. On the flip side, Alex Platt at D.A. Davidson raised his target to $125, arguing that “getting capacity online fast” remains crucial. TipRanks
For traders, attention is locked on a handful of immediate issues: the speed at which new data centers turn billable, shifts in financing terms, and the level at which margins stabilize following an early decline. Capital expenditure—essentially upfront spending on things like servers and physical sites—tends to drag on earnings long before any revenue materializes.
Legal hurdles are coming into play, too. The Schall Law Firm said in a PR Newswire release that it’s kicking off a securities class action and is urging anyone who bought CoreWeave shares from March 28, 2025 through Dec. 15, 2025 to think about applying for lead-plaintiff status by March 13. The complaint claims CoreWeave overstated its ability to meet demand and didn’t reveal risks linked to relying heavily on a single data-center vendor.
CoreWeave is back in the spotlight, with its executives set to speak at Morgan Stanley’s TMT conference on March 4. Investors are pushing for hard details—where exactly the spending starts to taper, how the funding plan stacks up, and the timeline for margin improvement.
